EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Get the Brief in your inbox

A daily, SEC-grounded read on the market — movers, earnings, and our boldest calls. Free.

EEDGAR/calls

SEC-grounded equity research — opinionated calls reasoned over real filings.

Research

  • The Brief
  • Markets
  • All Stocks
  • Screener
  • Discover
  • Research
  • The Flip Side
  • Track record

Tools

  • Compare
  • Congress trades
  • Events
  • Filing search
  • Groups
  • Trending
  • News

More

  • Pricing
  • Community
  • Newsletter
  • Developers / API
  • Account
DisclosuresTermsPrivacy

Research & education only — not financial advice. EDGAR is not a registered investment adviser; calls are impersonal, generated from SEC filings and a delayed/third-party price feed, and may be wrong or out of date. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates — see Disclosures. Do your own research.

EDGAR® is a registered trademark of the U.S. Securities and Exchange Commission. EDGAR/calls is not affiliated with, endorsed by, or approved by the U.S. Securities and Exchange Commission.

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity

Pulling SEC filings + quote and writing the call…

EEDGAR/calls
The BriefMarketsAll StocksNewsScreenerCommunity
← New search
Home›Stocks›DCGO

DCGO

DocGo Inc.

Next earnings Aug 5, 2026 (after close) · consensus $-0.07 EPS, $76.9M rev

Last earnings +3.9% on 2026-05-11

Avoid
$0.49
▲ +6.52%
$0.49▼ -71.01%
over 1Y
L $0.46EODHDH $1.73
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+6.5%
1W-8.1%
1M-22.6%
3M-14.8%
YTD-44.8%
1Y-71.0%
OverviewFinancialsValuationQualityTimelineFilings
Rating
Avoid
Quality
D
Valuation
Fair value
Filings
Flagged
Avoid
Conviction
Horizon
Medium (3–12mo)
Street · 11 analysts
Buy

Conservative balance sheet (liabilities/equity 0.63x); but revenue fell -47.7% YoY.

Revenue (FY2025) $322M · FY2025

DocGo Inc. shows $322M in FY2025 revenue (-47.7% YoY), a -56.6% net margin, and -126.7% ROE.

Financials · annual, by fiscal year

Line itemFY21FY22FY23FY24FY25
Revenue$319M$441M$624M$617M$322M
Gross profit—————
Operating income$15.4M$21.8M$15.1M$28.7M-$178M
Net income$23.7M$34.6M$6.86M$20.0M-$182M
Diluted EPS$0.25$0.34$0.06$0.18-$1.84
Net margin7.4%7.9%1.1%3.2%-56.6%

Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.

Key statistics

Valuation

Enterprise value-$2.40M
EV / EBITDA—
EV / Sales-0.0
EV / FCF-0.1
P / FCF1.6
PEG (trailing)—
Earnings yield-377.0%
FCF yield61.8%

Quality & risk

ROIC (est.)-97.5%
Free cash flow$29.9M
Total debt$236K
Net cash$50.8M
Altman Z-Score-1.62 distress
Piotroski F-Score4/8

Capital returns

Buyback yield22.4%
Dividend yield (est.)—
Shareholder yield22.4%
Shares Δ YoY-3.2%

Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.

Disclosure timeline

SEC · 8-Ks + reports
Red flag in recent filings — delisting notice (2026-01-30). Worth a closer look.
  1. 8-K Shareholder vote2026-06-18
  2. 8-K Earnings results2026-05-11
  3. 10-Q Quarterly report2026-05-11
  4. 8-K Officer / director change2026-04-22
  5. DEF 14A Proxy statement2026-04-22
  6. 8-K Earnings results2026-03-16
  7. 10-K Annual report2026-03-16
  8. 8-K Delisting notice2026-01-30
  9. 8-K Reg FD disclosure2025-12-12

Recent filings

all on EDGAR ↗
8-KPeriod ending 2026-06-162026-06-18open ↗4Period ending 2026-05-122026-05-14open ↗10-QPeriod ending 2026-03-312026-05-11open ↗8-KPeriod ending 2026-05-112026-05-11open ↗ARSPeriod ending 2025-12-312026-04-22open ↗DEFA14AFiling2026-04-22open ↗DEF 14APeriod ending 2026-06-162026-04-22open ↗8-KPeriod ending 2026-04-172026-04-22open ↗PRE 14APeriod ending 2026-04-102026-04-10open ↗4Period ending 2026-03-302026-03-31open ↗SCHEDULE 13G/AFiling2026-03-26open ↗S-8Filing2026-03-17open ↗

Quality score

D
ValueGrowthProfitHealthMom.
ValueA+
GrowthF
ProfitabilityF
Financial healthC+
Momentum—
  • ✗Revenue growing year-over-year
  • ✗Profitable (positive net income)
  • ✗Net margin above 10%
  • ✗Return on equity above 15%
  • ✓Liabilities below 2× equity
Revenue
$322M
-47.7% YoY
Net margin
-56.6%
ROE
-126.7%
P/E
—

SEC fundamentals · FY 2025

'21'22'23'24'25

■ revenue · ■ net income, by fiscal year

Revenue$322M-47.7%
Net income-$182M-1012.4%
Operating income-$178M-720.6%
Diluted EPS-$1.84-1122.2%
Cash & equivalents$51.0M-42.8%
Total assets$217M-52.4%
Total liabilities$91.2M-35.0%
Stockholders' equity$144M-55.1%
Op.: -55.3%L/E: 0.63x

Frequently asked

Is DocGo Inc. (DCGO) a buy?
DCGO currently carries a Avoid rating with 4/5 conviction, derived from its latest SEC filings. Conservative balance sheet (liabilities/equity 0.63x); but revenue fell -47.7% YoY.
What is DocGo Inc.'s quality score?
DCGO scores 46.764705882352935/100 (grade D) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.

Sources: SEC EDGAR (CIK 0001822359, latest 10-Q filed 2026-05-11) · EODHD · as of 6/24/2026, 2:29:17 PM.

Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.

Insider activity

Form 4 · SEC
2026-05-12
Bienstock Lee
Chief Executive Officer
Tax15.6K @ $0.59$9.23K
2026-03-30
Bienstock Lee
Chief Executive Officer
Tax18.8K @ $0.57$10.7K
2025-12-15
Bienstock Lee
Chief Executive Officer
Tax214K @ $0.91$195K
2025-12-15
ROSENBERG NORMAN
CFO and Treasurer
Tax65.8K @ $0.91$59.9K
2025-12-15
Sugrue Stephen
Chief Compliance Officer
Tax36.0K @ $0.91$32.7K
2025-12-15
Tendler Ely D
General Counsel and Secretary
Sell16.9K @ $0.91$15.3K
2025-12-12
Bienstock Lee
Chief Executive Officer
Award1.11M
2025-12-12
ROSENBERG NORMAN
CFO and Treasurer
Award429K
2025-12-12
Sugrue Stephen
Chief Compliance Officer
Award321K
2025-12-12
Tendler Ely D
General Counsel and Secretary
Award100K
2025-12-12
Burdiek Michael J
Director
Award150K
2025-12-12
Leite Etalvina
Director
Award150K

Earnings history

beat/miss · move
2026-05-11Miss -36.6% est▲ +3.86%8-K ↗
2026-03-16Miss -920.1% est▼ -1.48%8-K ↗
2025-11-10Beat +4.2% est▲ 0.00%8-K ↗
2025-08-07Miss -14.3% est▼ -1.42%8-K ↗
2025-05-08—▼ -2.92%8-K ↗
2025-02-27—▼ -3.45%8-K ↗

Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.

Recent news

market news →
DocGo Announces Upcoming Participation at the Goldman Sachs 47th Annual Global Healthcare ConferenceBullish
finance.yahoo.com· 2026-05-26
How The DocGo (DCGO) Story Is Shifting As Transport Optimism Meets Lower Valuation TargetsBullish
finance.yahoo.com· 2026-05-16
DocGo Targets Profitability as It Pivots to Mobile Health, Medical TransportBullish
finance.yahoo.com· 2026-05-16
DocGo Q1 Earnings Call HighlightsBullish
finance.yahoo.com· 2026-05-11
April 2026's Top Penny Stocks To WatchBullish
finance.yahoo.com· 2026-04-22
How DocGo (DCGO) Is Rewriting Its Story As Targets Fall And Transport Gains FocusBullish
finance.yahoo.com· 2026-04-08

Vs tracked universe

compare →

1044 tracked peers · median

EDGAR Score47 vs 67
Revenue growth-47.7% vs 7.1%
Net margin-56.6% vs 10.5%
Return on equity-126.7% vs 12.3%
P/E— vs 25.5

News sentiment

EODHD · 3d
Bullish
+0.18
vs typical · 4 articles
↑ improving

Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.